Why Metformin Causes Lactic Acidosis
Metformin causes lactic acidosis primarily through drug accumulation when renal clearance is impaired, leading to inhibition of mitochondrial respiration and subsequent lactate overproduction, particularly in the liver. 1, 2
Primary Mechanism: Renal Accumulation and Mitochondrial Dysfunction
Metformin is excreted unchanged by the kidneys, and when renal function declines, the drug accumulates to toxic levels. 3 The FDA label explicitly states that metformin accumulation risk increases with severity of renal impairment because the drug is substantially excreted by the kidney. 1
At the cellular level, accumulated metformin inhibits mitochondrial oxidative phosphorylation (specifically Complex I of the respiratory chain), which triggers a cascade of metabolic derangements: 4, 2
- ATP depletion occurs from impaired mitochondrial respiration 5
- Acceleration of glycolytic flux compensates for energy deficit 5
- Increased lactate production results from enhanced glycolysis 2
- Decreased hepatic lactate clearance occurs because the liver normally clears lactate but becomes a lactate producer when metformin inhibits mitochondrial function 5
The Liver as the Key Organ
The liver is the critical organ for both metformin's therapeutic effect and lactic acidosis development. 5 Metformin decreases liver uptake of lactate, increasing blood lactate levels. 1 When mitochondrial function is impaired by toxic metformin levels, lactate effluxes into circulation rather than being oxidized, and the liver switches from lactate clearance to lactate production. 5
The "Two-Hit" Phenomenon
Most cases of metformin-associated lactic acidosis (MALA) require both drug accumulation AND a secondary precipitating event. 3, 2 The ADA/KDIGO consensus emphasizes that most episodes occur concurrent with acute illness, often when acute kidney injury contributes to reduced metformin clearance. 3
Secondary precipitants that disrupt lactate metabolism include: 1
- Acute kidney injury from any cause (surgery, contrast agents, dehydration) 3
- Hypoxic states: heart failure, shock, myocardial infarction, sepsis 1
- Hepatic impairment: reduces lactate clearance capacity 1
- Excessive alcohol consumption: ethanol oxidation consumes NAD+ required for lactate metabolism 4, 6
- Tissue hypoperfusion and hypoxemia 3
Dose-Response Relationship
There is a clear correlation between metformin plasma levels, lactate concentration, and mortality. 7 A French pharmacovigilance study of 727 cases demonstrated:
- Metformin levels and lactate levels are significantly correlated (P < 0.001) 7
- Mortality was 30% when metformin concentration exceeded 5 mg/L versus 11% when below 5 mg/L (P = 0.003) 7
- Mean metformin levels were 37.4 mg/L in deceased patients versus 25.2 mg/L in survivors (P = 0.002) 7
However, the KDOQI guideline notes that even at reduced GFR (30-60 mL/min/1.73 m²), metformin concentrations are only about 2-fold higher than normal and still only 3% of levels found in true MALA cases. 3
Clinical Context: Actual Risk is Very Low
Despite the mechanistic risk, the actual incidence of lactic acidosis in clinical practice is extremely low (<10 cases per 100,000 patient-years). 2 The Canadian Society of Nephrology reported no cases of lactic acidosis in 37,360 metformin patient-years in a Cochrane meta-analysis. 3
The overall risk for metformin-associated lactic acidosis is low, and metformin may even be protective in cases of severe lactic acidosis unrelated to the drug. 5 Direct metformin-related mortality is close to zero when used appropriately. 5
Important Caveats
- Metformin itself does not directly cause hypoglycemia or lactic acidosis under normal conditions 3
- Renal dysfunction is only a prerequisite for accumulation—it becomes dangerous primarily when combined with liver failure or other precipitants 5
- The mortality rate for established MALA approaches 50%, making prevention through appropriate patient selection critical 2
- Metformin clearance decreases by approximately 75% when GFR falls to 60 mL/min/1.73 m² 3